NYSE:ZBH Zimmer Biomet Q3 2026 Earnings Date & Estimates $88.72 -0.16 (-0.18%) As of 01:52 PM Eastern This is a fair market value price provided by Massive. Learn more. Zimmer Biomet is scheduled to report Q3 2026 earnings on Wednesday, November 4, 2026, before market opens. The conference call is scheduled for 8:30 AM ET. Research:ProfileEarnings HistoryForecast Upcoming Earnings Announcement QuarterQ3 2026Announcement DateNovember 4, 2026TimeBefore Market OpensConference Call8:30 AM ET Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) What Analysts Expect from Zimmer Biomet in Q3 2026Zimmer Biomet is expected to post earnings of $1.88 per share on revenue of $2.04 billion. In the same quarter a year earlier Zimmer Biomet reported $1.90 per share on revenue of $2.00 billion. Zimmer Biomet last reported on August 5, 2026, posting $2.07 per share and beating the $2.01 consensus estimate. Zimmer Biomet has beaten the consensus EPS estimate in 7 of its last 8 quarters.Consensus EstimatesConsensus EPS$1.88Expected Revenue$2.04 billionPrior-Year EPS$1.90Prior-Year Revenue$2.00 billionExpected EPS Growth-1.1%Expected Revenue Growth+1.9%Recent Track RecordLast ReportedQ2 2026Last Quarter EPS$2.07 (Beat by +$0.06)Last Quarter Revenue$2.18 billionEPS Beat Rate7 of last 8 quartersPrepare for the Q3 2026 CallEarnings HistoryCompany ProfileQ2 2026 Earnings ReportQ1 2026 Earnings ReportQ4 2025 Earnings Report Zimmer Biomet Q3 2026 Earnings FAQ When does Zimmer Biomet report Q3 2026 earnings? Zimmer Biomet (NYSE:ZBH) is scheduled to report Q3 2026 earnings on Wednesday, November 4, 2026, before market opens. What time is Zimmer Biomet's Q3 2026 earnings call? Zimmer Biomet's Q3 2026 earnings conference call is scheduled for Wednesday, November 4, 2026 at 8:30 AM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date. What is the consensus EPS estimate for Zimmer Biomet? Analysts expect Zimmer Biomet to post earnings of $1.88 per share for Q3 2026. How much revenue is Zimmer Biomet expected to report? The consensus revenue estimate for Zimmer Biomet is $2.04 billion for Q3 2026. Zimmer Biomet Earnings HeadlinesBarclays initiates coverage of Zimmer Biomet Holdings at equal-weightOctober 8 at 5:28 PM | msn.comZimmer Biomet (NYSE:ZBH) Raised to Hold at BarclaysOctober 8 at 6:01 AM | americanbankingnews.comSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from collapsing — and billionaire Sam Altman is now an investor. This under-the-radar firm is drawing serious attention from those watching the energy infrastructure space closely.October 9 at 1:00 AM | Altimetry (Ad)Contrasting Zimmer Biomet (NYSE:ZBH) & Nyxoah (NASDAQ:NYXH)October 8 at 4:45 AM | americanbankingnews.comEvercore ISI Adjusts Zimmer Biomet Price Target to $115 From $110October 7 at 8:30 PM | finance.yahoo.comZimmer Biomet Announces Webcast and Conference Call of Third Quarter 2026 Financial ResultsOctober 6 at 7:30 AM | prnewswire.comSee More Zimmer Biomet Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Zimmer Biomet? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Zimmer Biomet and other key companies, straight to your email. Email Address About Zimmer BiometZimmer Biomet (NYSE:ZBH) (NYSE: ZBH) is a global medical device company focused on musculoskeletal healthcare. The company develops, manufactures and markets products used in orthopedic surgery, including total and partial knee, hip and shoulder replacement systems, sports medicine products, extremities, trauma devices and related surgical technologies. Its portfolio also includes orthopedic surgical equipment, robotic- and computer-assisted technologies, biologics and other solutions designed to support joint reconstruction, spine procedures and dental applications. Zimmer Biomet sells its products to hospitals, ambulatory surgery centers and healthcare professionals. Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer Biomet serves healthcare markets worldwide through direct operations and independent distributors. The company has expanded its offerings through internal development and acquisitions, including the acquisition of Biomet in 2015, which created the current Zimmer Biomet organization. Ivan Tornos serves as the company’s president and chief executive officer.View Zimmer Biomet ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Palantir’s Rally Puts Wall Street in Catch-Up Mode Ahead of November EarningsApplied Digital’s Hidden Moat Could Unlock Massive UpsideLevi's Stock Dip Reveals Value Opportunity Despite Q3 HeadwindsTilray Finds a Path to Growth Without Waiting on U.S. Cannabis ReformPepsiCo Stock Looks Poised to Bottom With High Yield, Deep ValueMicrosoft Is Almost Back to $555—Now the Hard Part BeginsSkydance Just Became a Media Giant—With an $80 Billion Debt Load Upcoming Earnings Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026)Wells Fargo & Company (10/13/2026)Johnson & Johnson (10/13/2026)UnitedHealth Group (10/13/2026)Bank of America (10/14/2026)BlackRock (10/14/2026)Morgan Stanley (10/14/2026)Progressive (10/14/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
